- Datum30.06.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Altan Cantürk
Moderator
Avadel Pharmaceuticals PLC Registered Shares (Sp.ADRs)/1 Aktie
Verkaufen
Kaufen
Avadel Pharmaceuticals PLC Registered Shares (Sp.ADRs)/1 Chart
Echtzeit-News zu diesem und anderen Unternehmen findest Du hier!
Live-Ticker Avadel Pharmaceuticals PLC Registered Shares (Sp.ADRs)/1 Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-0,97 %
Intraday
0,22 %
1 Woche
-0,22 %
1 Monat
-12,46 %
Seit Jahresbeginn
-34,57 %
1 Jahr
293,16 %
3 Jahre
15,87 %
5 Jahre
Passender Service zu Avadel Pharmaceuticals PLC Registered Shares (Sp.ADRs)/1
Webinar zu Avadel Pharmaceuticals PLC Registered Shares (Sp.ADRs)/1
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)6,380-17,298
- Jahrestief / Hoch ($)6,380-11,520
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Avadel Pharmaceuticals PLC Registered Shares (Sp.ADRs)/1
Keine Dividenden verfügbar
Termine von Avadel Pharmaceuticals PLC Registered Shares (Sp.ADRs)/1
Keine aktuellen Termine
Beschreibung
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
